Global Vascular Graft Market - Forecasts from 2018 to 2023
Global vascular graft market is projected to witness a CAGR of 6.52% over the forecast period of 2017-2023. Vascular grafts are the materials used to patch injured or diseased areas of the arteries, replacements of the damaged segments of the larger arteries such as aorta. The graft is introduced through a surgical procedure to redirect the blood flow from one part to another. The biocompatibility of the grafts coupled with the sturdiness make them ideal for enhancing the vascular access through surgeries.
Rising Prevalence of the Cardiac Diseases and Coronary Artery Diseases to Boost the Market
The growth in the market may be attributed to the rising prevalence of the cardiac diseases, coronary artery diseases, hypertension, renal diseases and cardiac aneurysms. As per data by WHO, around 17.7 million people die each year from Cardiovascular Diseases, constituted nearly 31% of the global mortality rate. Rising geriatric population will further augment the growth of the market during the forecast period. Unhealthy lifestyle and factors such as rising adoption of the smoking and drinking habits have also increased the risk of diabetes and coronary artery diseases, thereby increasing the requirements of vascular grafts and providing ample opportunities for the companies to enter the market. Advancements in graft materials and introduction of biomaterials will also significantly bolster the market growth during the forecast period. However, high procedure cost and complications associated with surgeries such as bleeding, arrhythmias and infection might restrain the vascular graft market growth during the forecast period.
North America to Dominate the Vascular Graft Market
Geographically, North America is expected to dominate the market owing to the high number of lifestyle related diseases, specifically hypertension and coronary artery diseases. According to statistics released by the American Heart Association, approximately 84 million people in the U.S. suffer from some form of cardiovascular disease, causing about 2,200 deaths a day. Presence of skilled workforce, favorable reimbursement policies and proper healthcare infrastructure will further boost the market in the region. Asia Pacific is expected to show the fastest growth owing to the rising number of patients suffering from cardiovascular diseases and improving healthcare facilities in the region.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global vascular grafts market.
Major industry players profiled as part of the report are Hancock Jaffe Laboratories, Inc., W. L. Gore & Associates and Vascular Genesis among others.
Segmentation
Rising Prevalence of the Cardiac Diseases and Coronary Artery Diseases to Boost the Market
The growth in the market may be attributed to the rising prevalence of the cardiac diseases, coronary artery diseases, hypertension, renal diseases and cardiac aneurysms. As per data by WHO, around 17.7 million people die each year from Cardiovascular Diseases, constituted nearly 31% of the global mortality rate. Rising geriatric population will further augment the growth of the market during the forecast period. Unhealthy lifestyle and factors such as rising adoption of the smoking and drinking habits have also increased the risk of diabetes and coronary artery diseases, thereby increasing the requirements of vascular grafts and providing ample opportunities for the companies to enter the market. Advancements in graft materials and introduction of biomaterials will also significantly bolster the market growth during the forecast period. However, high procedure cost and complications associated with surgeries such as bleeding, arrhythmias and infection might restrain the vascular graft market growth during the forecast period.
North America to Dominate the Vascular Graft Market
Geographically, North America is expected to dominate the market owing to the high number of lifestyle related diseases, specifically hypertension and coronary artery diseases. According to statistics released by the American Heart Association, approximately 84 million people in the U.S. suffer from some form of cardiovascular disease, causing about 2,200 deaths a day. Presence of skilled workforce, favorable reimbursement policies and proper healthcare infrastructure will further boost the market in the region. Asia Pacific is expected to show the fastest growth owing to the rising number of patients suffering from cardiovascular diseases and improving healthcare facilities in the region.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global vascular grafts market.
Major industry players profiled as part of the report are Hancock Jaffe Laboratories, Inc., W. L. Gore & Associates and Vascular Genesis among others.
Segmentation
- By Source
- Synthetic
- Semi Synthetic
- Natural
- By Indication
- Cardiovascular Diseases
- Renal Diseases
- Aneurysms
- Others
- By End-User
- Hospitals
- Ambulatory Surgical Centres
- By Geography
- North America
- United States
- Canada
- Others
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Others
- Middle East and Africa
- Israel
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- China
- India
- Australia
- South Korea
- Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL VASCULAR GRAFT MARKET FORECAST BY SOURCE
5.1. Synthetic
5.2. Semi Synthetic
5.3. Natural
6. GLOBAL VASCULAR GRAFT MARKET FORECAST BY INDICATION
6.1. Cardiovascular Diseases
6.2. Renal Diseases
6.3. Aneurysms
6.4. Others
7. GLOBAL VASCULAR GRAFT MARKET FORECAST BY END-USER
7.1. Hospitals
7.2. Ambulatory Surgical Centres
8. GLOBAL VASCULAR GRAFT MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. Saudi Arabia
8.4.3. UAE
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Hancock Jaffe Laboratories, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Development
10.2. Vascutek Ltd.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Development
10.3. MAQUET Holding B.V. & Co. KG
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Development
10.4. W. L. Gore & Associates
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Development
10.5. Vascular Flow Technologies
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Development
10.6. C. R. Bard, Inc.
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Development
10.7. Artegraft Inc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Development
10.8. Vascular Genesis
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Development
10.9. B. Braun Melsungen AG
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Development
10.10. LeMaitre Vascular, Inc.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Development
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL VASCULAR GRAFT MARKET FORECAST BY SOURCE
5.1. Synthetic
5.2. Semi Synthetic
5.3. Natural
6. GLOBAL VASCULAR GRAFT MARKET FORECAST BY INDICATION
6.1. Cardiovascular Diseases
6.2. Renal Diseases
6.3. Aneurysms
6.4. Others
7. GLOBAL VASCULAR GRAFT MARKET FORECAST BY END-USER
7.1. Hospitals
7.2. Ambulatory Surgical Centres
8. GLOBAL VASCULAR GRAFT MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. Saudi Arabia
8.4.3. UAE
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Hancock Jaffe Laboratories, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Development
10.2. Vascutek Ltd.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Development
10.3. MAQUET Holding B.V. & Co. KG
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Development
10.4. W. L. Gore & Associates
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Development
10.5. Vascular Flow Technologies
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Development
10.6. C. R. Bard, Inc.
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Development
10.7. Artegraft Inc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Development
10.8. Vascular Genesis
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Development
10.9. B. Braun Melsungen AG
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Development
10.10. LeMaitre Vascular, Inc.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Development
